Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127403171 | 12740317 | 1 | I | 20091117 | 20160907 | 20160913 | 20160913 | EXP | US-AMNEAL PHARMACEUTICALS-2016AMN00510 | AMNEAL | 72.00 | YR | F | Y | 82.99000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127403171 | 12740317 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | (375 OR 500MG TWICE A DAY) | Y | 75927 | ||||||||||
127403171 | 12740317 | 2 | C | QUINAPRIL. | QUINAPRIL | 1 | Oral | UNK (20/12.5) ONCE DAILY | 0 | QD | |||||||||
127403171 | 12740317 | 3 | C | esoprazole (Nexium) | 2 | Oral | UNK, 2X/DAY | 0 | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127403171 | 12740317 | 1 | Osteoarthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127403171 | 12740317 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127403171 | 12740317 | Atelectasis | |
127403171 | 12740317 | Chest pain | |
127403171 | 12740317 | Gastritis | |
127403171 | 12740317 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127403171 | 12740317 | 1 | 20070922 | 20091117 | 0 |